Recent studies have shown that the mutation and inactivation of serine threonine protein kinase 11 (STK11) are closely related to the occurrence of malignant tumors, especially playing an important role in the pathogenesis and outcome of a variety of adenocarcinomas [8, 9]. The gene discussed is STK11; the disease is cancer.